Medicare Enrolled

Dr. Spyros Mezitis, MD, PHD

Endocrinology · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
220 E 69TH ST, New York, NY 10021
2122886661
In practice since 2006 (19 years)
NPI: 1013078732 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mezitis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mezitis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mezitis

Dr. Spyros Mezitis is an endocrinology specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mezitis performed 3,442 Medicare services across 413 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mezitis received a total of $24,510 from 39 pharmaceutical and/or device companies across 454 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mezitis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 19% volume in NY $24,510 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,442
Medicare services
Top 19% in NY for endocrinology
413
Unique beneficiaries
$134
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~181 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
3,028 $150 $270
Blood glucose level test
A test that measures the amount of sugar in your blood.
159 $4 $9
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
159 $10 $34
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
77 $8 $13
New patient office visit, complex (60-74 min) 19 $176 $1,040
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$24,510
Total received (2018-2024)
Avg $3,501/year across 7 years
Top 14% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
454
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,360 (66.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,150 (33.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,099
2023
$3,143
2022
$2,277
2021
$2,220
2020
$3,497
2019
$7,093
2018
$5,181

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$312
Boehringer Ingelheim Pharmaceuticals, Inc.
$285
PFIZER INC.
$89
Lilly USA, LLC
$68
Amgen Inc.
$66
IBSA Pharma Inc.
$43
Astellas Pharma US Inc
$42
Novo Nordisk Inc
$41
Xeris Pharmaceuticals, Inc.
$40
Antares Pharma, Inc.
$34
Intra-Sana Laboratories
$26
Chiesi USA, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$18
Tolmar, Inc.
$13
Top 3 companies account for 62.4% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$8,931
AbbVie Inc.
$4,063
ABBVIE INC.
$3,677
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,685
Novo Nordisk Inc
$828
AstraZeneca Pharmaceuticals LP
$697
SANOFI-AVENTIS U.S. LLC
$621
PFIZER INC.
$607
Lilly USA, LLC
$602
Corcept Therapeutics
$543
Merck Sharp & Dohme Corporation
$312
Amgen Inc.
$250
Mannkind Corporation
$249
Aytu BioScience, Inc
$216
IBSA Pharma Inc.
$149
Abbott Laboratories
$132
Shire North American Group Inc
$130
Intra-Sana Laboratories
$109
Astellas Pharma US Inc
$76
Ultragenyx Pharmaceutical Inc.
$70
Xeris Pharmaceuticals, Inc.
$60
Insulet Corporation
$55
Antares Pharma, Inc.
$54
Kyowa Kirin, Inc.
$50
Aytu Bioscience, Inc
$44
Alexion Pharmaceuticals, Inc.
$43
Medtronic, Inc.
$32
Acerus Pharmaceuticals Corporation
$30
Horizon Therapeutics plc
$23
Chiesi USA, Inc.
$21
Amryt Pharma Holdings Ltd
$21
Avion Pharmaceuticals
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Seqirus USA Inc
$18
Currax Pharmaceuticals LLC
$17
Eisai Inc.
$16
Radius Health, Inc.
$15
Amneal Pharmaceuticals LLC
$14
Tolmar, Inc.
$13
Top 3 companies account for 68.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · Balcoltra · Belviq · CONTRAVE · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · Fluad · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE PFS · JANUMET · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LANTUS · LICART · MOUNJARO · MYCAPSSA · Minimed 770G System · NATPARA · Natesto · OTREXUP · Omnipod · Ozempic · Prolia · RECORLEV · RELTONE 200 MG · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tresiba · Tymlos · UNITHROID · Veozah · Victoza · Wegovy · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (67%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware.

Looking for an endocrinology specialist in New York?
Compare endocrinologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
676
Per 100K population
41.5
County median income
$104,553
Nearest hospital
HOSPITAL FOR SPECIAL SURGERY
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mezitis is a clinical cardiology specialist, with above-average Medicare volume (top 19% in NY), with speaking/promotional industry engagement in the top 14% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mezitis experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Mezitis performed 3,028 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mezitis receive payments from pharmaceutical companies?
Yes. Dr. Mezitis received a total of $24,510 from 39 companies across 454 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mezitis's costs compare to other endocrinologists in New York?
Dr. Mezitis's average Medicare payment per service is $134. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mezitis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →